SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Full list of Israeli high-tech funding rounds in 2025

Syremis raises $165 million Series A to take on schizophrenia and other severe mental illnesses

Iron Dome and Iron Beam maker Rafael moves closer to a possible IPO

Weapons as strategy: Israel’s defense industry steps into a larger global role

Buzz

Most popular

Daily

Weekly

1

Huang declares Israel Nvidia’s “second home” with record-breaking campus investment

2

Cyera raises $400 million at $9 billion valuation in Blackstone-led round

3

Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation

4

Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal

5

“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”

Clal Biotechnology Industries

5 stories about Clal Biotechnology Industries

עפר גונן מנכ"ל כלל ביוטכנולוגיה

CBI plans to issue new SPAC to merge with Israeli life science company

18.03.21|Hezi Sternlicht

The Israeli biotech giant plans to raise $100 million on Nasdaq to acquire a company that’s involved in advanced healthcare solutions

הדמיה חיסון תרופה קורונה covid 19

Elicio Therapeutics enters Covid-19 vaccine race, reports success in pre-clinical trials

19.08.20|Sophie Shulman

Boston company partially owned by Clal Biotechnology Industries plans to advance to clinical trials in Q4

Sight Diagnostics raises $71 million amidst Covid-19 demand for blood count devices

Israeli startup develops machine vision-based technology for blood test analysis and infectious disease diagnosis

חדר מיון בית חולים שיבא תל השומר

Cost-Cutting at CureTech Following Cancellation of Acquisition Deal with Insight

The deal was announced in March, but intended buyer InSight backed out

לן בלווטניק בעל השליטה בכת"ב

Three Portfolio Companies of Len Blavatnik's Clal Biotechnology Raise Cash in One Week

Clal Biotechnology Industries is an Israel-based life sciences investment company